Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.56 |
| ▸ | ACHE | P22303 | 2/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TACR2 | P21452 | 3/20 | 0.43 |
| ▸ | NT5E | P21589 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.40 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.40 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.40 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.40 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.39 |
| ▸ | CDC25B | P30305 | 5/20 | 0.39 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.39 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.39 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.39 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13112800 | 1.00 | BCHE (0.56) | BCHEACHEHTR1ALMNATACR2 | |
| SCHEMBL13956209 | 1.00 | BCHE (0.56) | BCHEACHEHTR1ALMNATACR2 | |
| SCHEMBL16027502 | 1.00 | BCHE (0.56) | BCHEACHEHTR1ALMNATACR2 | |
| SCHEMBL12407911 | 1.00 | BCHE (0.56) | BCHEACHEHTR1ALMNATACR2 | |
| SCHEMBL1087871 | 1.00 | BCHE (0.56) | BCHEACHEHTR1ALMNATACR2 | |
| SCHEMBL500473 | 1.00 | BCHE (0.56) | BCHEACHEHTR1ALMNATACR2 | |
| SCHEMBL18511226 | 1.00 | BCHE (0.56) | BCHEACHEHTR1ALMNATACR2 | |
| SCHEMBL22129916 | 1.00 | BCHE (0.56) | BCHEACHEHTR1ALMNATACR2 | |
| SCHEMBL22330780 | 1.00 | BCHE (0.56) | BCHEACHEHTR1ALMNATACR2 | |
| SCHEMBL13956220 | 1.00 | BCHE (0.56) | BCHEACHEHTR1ALMNATACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2076503-B1 | C-PHENYL GLYCITOL COMPOUND FOR THE TREATMENT OF DIABETES | TAISHO PHARMACEUTICAL CO LTD (JP) | 2013-07-17 | — | — | EP | disclosed |
| US-8236935-B2 | Gem-difluorinated C-glycoside compounds derived from podophyllotoxin, their preparation and their applications | INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE ROUEN (INSA) (FR) | 2012-08-07 | — | — | US | disclosed |
| US-8236935-B2 | Gem-difluorinated C-glycoside compounds derived from podophyllotoxin, their preparation and their applications | INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE ROUEN (INSA) (FR) | 2012-08-07 | — | — | US | disclosed |
| US-7973012-B2 | C-phenyl glycitol compound | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2011-07-05 | — | — | US | disclosed |
| US-20100022460-A1 | C-PHENYL GLYCITOL COMPOUND | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2010-01-28 | — | — | US | disclosed |
| US-20090318675-A1 | NOVEL GEM-DIFLUORINATED C-GLYCOSIDE COMPOUNDS DERIVED FROM PODOPHYLLOTOXIN, THEIR PREPARATION AND THEIR APPLICATIONS | SUNSHINE BIOPHARMA INC. (CA) | 2009-12-24 | — | — | US | disclosed |
| US-20090318675-A1 | NOVEL GEM-DIFLUORINATED C-GLYCOSIDE COMPOUNDS DERIVED FROM PODOPHYLLOTOXIN, THEIR PREPARATION AND THEIR APPLICATIONS | SUNSHINE BIOPHARMA INC. (CA) | 2009-12-24 | — | — | US | disclosed |
| US-20090311203-A1 | GEM-DIFLUORIDE C-GLYCOPEPTIDE COMPOUNDS, THEIR PREPARATION AND USE PARTICULARLY FOR PRESERVATION OF BIOLOGICAL MATERIALS | INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE ROUEN (INSA) (FR) | 2009-12-17 | — | — | US | disclosed |
| EP-0701818-B1 | Therapeutic methods using catalytic antibodies | IGEN INT INC (US) | 2003-07-30 | — | — | EP | disclosed |
| EP-0521996-B1 | CATALYTIC ANTIBODY COMPONENTS | IGEN INT INC (US) | 2002-12-18 | — | — | EP | disclosed |
| US-5658753-A | Catalytic antibody components | WELLSTAT BIOCATALYSIS, LLC | 1997-08-19 | — | — | US | disclosed |
| EP-0701818-A2 | Therapeutic methods using catalytic antibodies | IGEN, INC. (US) | 1996-03-20 | — | — | EP | disclosed |
| EP-0436545-B1 | THERAPEUTIC METHODS USING CATALYTIC ANTIBODIES | IGEN INC (US) | 1996-03-13 | — | — | EP | disclosed |
| EP-0521996-A4 | CATALYTIC ANTIBODY COMPONENTS | — | 1993-06-30 | — | — | EP | disclosed |
| EP-0521996-A1 | CATALYTIC ANTIBODY COMPONENTS | IGEN, INC. (US) | 1993-01-13 | — | — | EP | disclosed |
| WO-1991014769-A1 | CATALYTIC ANTIBODY COMPONENTS | IGEN, INC. (US) | 1991-10-03 | — | — | WO | disclosed |
| EP-0436545-A1 | THERAPEUTIC METHODS USING CATALYTIC ANTIBODIES. | IGEN INC (US) | 1991-07-17 | — | — | EP | disclosed |
| EP-0436545-A4 | THERAPEUTIC METHODS USING CATALYTIC ANTIBODIES. | IGEN INC (US) | 1991-05-30 | — | — | EP | disclosed |
| WO-1989010754-A1 | THERAPEUTIC METHODS USING CATALYTIC ANTIBODIES | IGEN, INC. (US) | 1989-11-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022460-A1 | C-PHENYL GLYCITOL COMPOUND | SLC5A1, SLC5A2, SLC2A1 | BCHE 1269/4885ACHE 3646/4885HTR1A 2185/4885 |
| US-20090311203-A1 | GEM-DIFLUORIDE C-GLYCOPEPTIDE COMPOUNDS, THEIR PREPARATION AND USE PARTICULARLY FOR PRESERVATION OF BIOLOGICAL MATERIALS | B3GAT3, GMFG, GYPA | BCHE 3025/4885ACHE 4679/4885HTR1A 4859/4885 |
| US-20090318675-A1 | NOVEL GEM-DIFLUORINATED C-GLYCOSIDE COMPOUNDS DERIVED FROM PODOPHYLLOTOXIN, THEIR PREPARATION AND THEIR APPLICATIONS | GLRA3, GMNN, B3GAT3 | BCHE 2847/4885ACHE 2707/4885HTR1A 4160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.